Anavex awarded grant to fund clinical trial of Rett syndrome drug
January 19, 2017 at 07:00 AM EST
Anavex Life Sciences Corp. will receive funding for a phase 2 trial of its Anavex 2-73 drug from the International Rett Syndrome Foundation to study the rare neurological disorder.
